ANAB
Anaptysbio, Inc.
Clinical-stage biotechnology company focused on immunology therapeutics
CUSIP: 032724106HealthcareUS1 holder
Total Value
$47.59M
Total Shares
746.0K
Net Share Change
+136.1K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$47.59M746.0K shares
ADD+136.1K(+22.3%)